SLS stock

Sellas Life Sciences Group Inc (SLS) financials · $1.62B cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Sellas Life Sciences Group Inc (SLS) $1.62B cap.

Cached annual income statement
LineFY2025FY2024
Cost of RevenueN/AN/A
Operating Income-$28.3M-$31.5M
Net Income-$26.9M-$30.9M
EPS (Diluted)-$0.25-$0.50
Cached annual balance sheet
LineFY2025FY2024
Total Assets$78.3M$19.4M
Current Assets$75.2M$16.3M
Cash & Equivalents$71.8M$13.9M
Total Liabilities$7.47M$9.97M
Current Liabilities$7.02M$9.51M
Shareholders' Equity$70.9M$9.46M
Retained Earnings-$275.0M-$248.1M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$28.4M-$35.4M
Investing Cash FlowN/AN/A
Financing Cash Flow$86.3M$46.8M
Net Change in Cash$57.9MN/A
These statements as JSON? API free 100/day

FAQ

What is SLS P/E and revenue?

Sellas Life Sciences Group Inc (SLS) $1.62B cap.

What is SLS revenue?

SLS income-statement cache has no revenue figure yet.

Is SLS profitable?

Sellas Life Sciences Group Inc last cached net income is -$26.9M (FY2025).

What are SLS total assets?

Sellas Life Sciences Group Inc last cached total assets are $78.3M (FY2025).

What is SLS free cash flow?

No cached cash-flow row for SLS yet.

Not investment advice. Cached statements, not a live tape.